Devimistat in Combination with Gemcitabine and Cisplatin in Biliary Tract Cancer: Preclinical Evaluation and Phase Ib Multicenter Clinical Trial (BilT-04)
- Deepak Nagrath
- April 28, 2023
- kedalionlabs.com
- Arathi Mohan, Kent A Griffith, Fulei Wuchu, …, Deepak Nagrath, Mark M Zalupski, Vaibhav Sahai
- Clin Cancer Res, 10.1158/1078-0432.ccr-23-0036
Exploiting metabolic vulnerabilities after anti-VEGF antibody therapy in ovarian cancer
- Deepak Nagrath
- February 24, 2023
- kedalionlabs.com
- Deanna Glassman, Mark S Kim, Meredith Spradlin, …, Livia S Eberlin, Deepak Nagrath, Anil K Sood
- None, 10.1016/j.isci.2023.106020
Metabolic collateral lethal target identification reveals MTHFD2 paralogue dependency in ovarian cancer
- Deepak Nagrath
- September 21, 2022
- kedalionlabs.com
- Abhinav Achreja, Tao Yu, Anjali Mittal, …, Analisa DiFeo, Xiongbin Lu, Deepak Nagrath
- Nat Metab, 10.1038/s42255-022-00636-3
Driving with Both Feet: Supplementing AKG While Inhibiting BCAT1 Leads to Synthetic Lethality in GBM
- Deepak Nagrath
- July 5, 2022
- kedalionlabs.com
- Noah Meurs, Deepak Nagrath
- Cancer Res, 10.1158/0008-5472.can-22-1619
Radiotherapy-induced metabolic hallmarks in the tumor microenvironment
- Deepak Nagrath
- June 24, 2022
- kedalionlabs.com
- Anjali Mittal, Minal Nenwani, Itisam Sarangi, Abhinav Achreja, Theodore S Lawrence, Deepak Nagrath
- Trends Cancer, 10.1016/j.trecan.2022.05.005